Document Detail


[Evaluation of Bone ; Up Date from Research to Clinical Application. Bone metabolic markers for evaluation of bone metastases].
MedLine Citation:
PMID:  23445893     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Bone metabolic markers consist of bone formation markers, which are secreted from osteoblasts (BAP, OC, P1CP, P1NP) , and bone resorption markers, which are metabolites of bone type 1 collagen or secreted from osteoclasts (PYD, DPD, NTX, CTX, 1CTP, TRACP) . Those bone metabolic markers are useful for : (1) diagnosis of bone metastases, (2) follow-up during treatment of bone metastases, and (3)predicting prognosis of bone metastases.
Authors:
Shunji Takahashi
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Clinical calcium     Volume:  23     ISSN:  0917-5857     ISO Abbreviation:  Clin Calcium     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9433326     Medline TA:  Clin Calcium     Country:  Japan    
Other Details:
Languages:  jpn     Pagination:  391-400     Citation Subset:  IM    
Affiliation:
Dep. of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Evaluation of Bone ; Up Date from Research to Clinical Application. Clinical nuclear medicine in bo...
Next Document:  [Evaluation of Bone ; Up Date from Research to Clinical Application. Assessment of the treatment of ...